Outset Medical Stock Forecast, Price & News

+0.13 (+0.24 %)
(As of 04/16/2021 04:00 PM ET)
Today's Range
Now: $53.90
50-Day Range
MA: $51.95
52-Week Range
Now: $53.90
Volume257,305 shs
Average Volume381,976 shs
Market Capitalization$2.31 billion
P/E RatioN/A
Dividend YieldN/A
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Outset Medical logo

Industry, Sector and Symbol

Industry Electromedical equipment
Phone669 231 8200
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap$2.31 billion
Next Earnings Date6/8/2021 (Estimated)
OptionableNot Optionable


Outset Medical (NASDAQ:OM) Stock Price Down 7.7%
April 12, 2021 |
Outset Medical (NASDAQ:OM) Trading Up 5.3%
April 9, 2021 |
Outset Medical (NASDAQ:OM) Shares Gap Down to $58.10
April 7, 2021 |
Outset Medical (NASDAQ:OM) Sees Large Volume Increase
April 5, 2021 |
Outset Medical (NASDAQ:OM) Shares Down 5.4%
March 25, 2021 |
See More Headlines


Overall MarketRank

0.96 out of 5 stars

Medical Sector

1110th out of 2,025 stocks

Electromedical Equipment Industry

26th out of 61 stocks

Analyst Opinion: 1.3Community Rank: 1.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
+0.13 (+0.24 %)
(As of 04/16/2021 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OM News and Ratings via Email

Sign-up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Outset Medical (NASDAQ:OM) Frequently Asked Questions

Is Outset Medical a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Outset Medical stock.
View analyst ratings for Outset Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Outset Medical?

Wall Street analysts have given Outset Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Outset Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Outset Medical?

Outset Medical saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 1,260,000 shares, an increase of 35.2% from the February 28th total of 932,000 shares. Based on an average trading volume of 315,900 shares, the days-to-cover ratio is currently 4.0 days. Currently, 3.6% of the company's stock are short sold.
View Outset Medical's Short Interest

When is Outset Medical's next earnings date?

Outset Medical is scheduled to release its next quarterly earnings announcement on Tuesday, June 8th 2021.
View our earnings forecast for Outset Medical

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) released its quarterly earnings results on Monday, March, 8th. The company reported ($0.75) earnings per share for the quarter, missing analysts' consensus estimates of ($0.66) by $0.09. The business earned $17.25 million during the quarter, compared to analysts' expectations of $13.79 million.
View Outset Medical's earnings history

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical updated its first quarter 2021 After-Hours earnings guidance on Tuesday, March, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $21-22 million, compared to the consensus revenue estimate of $14.79 million.

What price target have analysts set for OM?

7 Wall Street analysts have issued 1-year price targets for Outset Medical's stock. Their forecasts range from $54.00 to $60.00. On average, they anticipate Outset Medical's share price to reach $56.50 in the next year. This suggests a possible upside of 4.8% from the stock's current price.
View analysts' price targets for Outset Medical
or view top-rated stocks among Wall Street analysts.

Who are Outset Medical's key executives?

Outset Medical's management team includes the following people:
  • Ms. Leslie L. Trigg, Pres, CEO & Director (Age 50, Pay $690.09k)
  • Ms. Rebecca Chambers, Chief Financial Officer (Age 43, Pay $485.79k)
  • Mr. Martin Vazquez, Chief Operating Officer (Age 51, Pay $591.49k)
  • Mr. John L. Brottem, Gen. Counsel & Sec. (Age 47)
  • Ms. Stacey Porter, Vice Pres of People Operations
  • Dr. Michael Aragon M.D., Chief Medical Officer
  • Ms. Tonya Saffer, Head of Gov. Affairs & Market Access
  • Mr. Steve Williamson, Chief Commercial Officer (Age 48)

Who are some of Outset Medical's key competitors?

When did Outset Medical IPO?

(OM) raised $175 million in an initial public offering (IPO) on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

What is Outset Medical's stock symbol?

Outset Medical trades on the NASDAQ under the ticker symbol "OM."

When did Outset Medical's lock-up period expire?

Outset Medical's lock-up period expired on Monday, March 15th. Outset Medical had issued 8,951,111 shares in its IPO on September 15th. The total size of the offering was $241,679,997 based on an initial share price of $27.00. Since the expiration of Outset Medical's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Who are Outset Medical's major shareholders?

Outset Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Columbia Trust Co 01012016 (0.18%) and Baldwin Brothers Inc. MA (0.00%). Company insiders that own Outset Medical stock include D Keith Grossman, John L Brottem, Leslie Trigg, Martin Vazquez, Pincus X LP Warburg, Rebecca Chambers and Warburg Pincus Llc.
View institutional ownership trends for Outset Medical

Which major investors are buying Outset Medical stock?

OM stock was acquired by a variety of institutional investors in the last quarter, including Columbia Trust Co 01012016, and Baldwin Brothers Inc. MA.
View insider buying and selling activity for Outset Medical
or or view top insider-buying stocks.

How do I buy shares of Outset Medical?

Shares of OM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Outset Medical's stock price today?

One share of OM stock can currently be purchased for approximately $53.90.

How much money does Outset Medical make?

Outset Medical has a market capitalization of $2.31 billion.

How many employees does Outset Medical have?

Outset Medical employs 313 workers across the globe.

What is Outset Medical's official website?

The official website for Outset Medical is

Where are Outset Medical's headquarters?

Outset Medical is headquartered at 3052 ORCHARD DRIVE, SAN JOSE CA, 95134.

How can I contact Outset Medical?

Outset Medical's mailing address is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. The company can be reached via phone at 669 231 8200 or via email at [email protected]

This page was last updated on 4/17/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.